Filing Details
- Accession Number:
- 0000899243-21-029479
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-22 16:46:41
- Reporting Period:
- 2021-07-20
- Accepted Time:
- 2021-07-22 16:46:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1783328 | Tscan Therapeutics Inc. | TCRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1291961 | H Christoph Westphal | C/O Tscan Therapeutics, Inc. 830 Winter Street Waltham MA 02451 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Acquisiton | 2021-07-20 | 1,145,505 | $0.00 | 1,145,505 | No | 4 | C | Indirect | See footnote |
| Voting Common Stock | Acquisiton | 2021-07-20 | 133,333 | $15.00 | 1,278,838 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Voting Common Stock | Series A Preferred Stock | Disposition | 2021-07-20 | 641,848 | $0.00 | 641,848 | $0.00 |
| Voting Common Stock | Series B Preferred Stock | Disposition | 2021-07-20 | 332,594 | $0.00 | 332,594 | $0.00 |
| Voting Common Stock | Series C Preferred Stock | Disposition | 2021-07-20 | 171,063 | $0.00 | 171,063 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Voting Common Stock | 914,634 | Direct | |
| Voting Common Stock | 121,951 | Indirect | See footnote |
Footnotes
- These shares are held by the Reporting Person's spouse.
- Each share of the Issuer's preferred stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.
- These shares are held by Longwood Fund IV, L.P. ("Longwood"). The general partner of Longwood is Longwood Fund IV GP, LLC ("Longwood GP"). Voting, investment and dispositive decisions at Longwood GP with respect to the securities held by Longwood are made by an investment committee comprised of Christoph Westphal, Richard Aldrich and John Lawrence (collectively, the "IC Members"). Longwood GP and each of the IC Members may be deemed to share voting, investment and dispositive power over the securities held by Longwood and as a result may be deemed to have beneficial ownership over such securities. Longwood GP and each of the IC Members disclaims beneficial ownership over the securities held by Longwood, except to the extent of their respective pecuniary interests therein.
- Represents shares purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
